Patient P-01798
Synthetic patientNBL-101 · Day 115 · 65–74 · F · baseline S08Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S08
- Day 50 NP-02 recommended — Dietary Support Protocol NP-02
- Day 51 Patient accepted — Started NP-02 in the companion
- Day 61 GI symptom burden −11% vs expected — Dietary Support Protocol NP-02
- Day 67 Tolerance state changed — Unstable → Improving
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity-13
- Inflammatory activity-2
What helped?
- Dietary Support Protocol NP-02Day 50Result: symptom burden −11%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion23.2/100
improving · -5.8 vs previous 14 d
Toxicity
Blood7.4/100
improving · -1.7 vs previous 14 d
Sleep quality
Wearable46/100
improving · +7.3 vs previous 14 d
Energy level
Daily log6.3/10
improving · +0.7 vs previous 14 d
Stress level
Daily log4/10
improving · -0.3 vs previous 14 d
Steps
Wearable5,361
stable · +205 vs previous 14 d
Adherence
Companion97 %
stable · +1.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 83 from the failing basin, 6 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Keep simple carbs lowGI +4.1 next day on high-intake days · n 14
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates+4.1detractor · 95%
- Dietary fat load-2.5no signal · 55%
- Alcohol+1.2no signal · 24%
- Insoluble fibre-0.7no signal · 15%
- Spicy / capsaicin+0.7no signal · 15%
- Histamine load+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 34 ms, trending down
- Autonomic recovery ↑25
- WearableResting HR 73 bpm
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.9 · butyrate capacity 65/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 30 ms
- Sleep
- 7.2 h
- Steps
- 5,684
- Resting HR
- 72 bpm
Daily log: GI score 23, nutritional resilience 65, adherence 97.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.